SUMMARY A pregnancy at risk for adenosine deaminase deficiency and severe combined immunodeficiency disease was investigated using samples of chorionic villi obtained during the eighth week of pregnancy. Adenosine deaminase levels suggested that the fetus was a probable carrier and that a diagnosis of severe combined immunodeficiency disease could be excluded. Enzyme and chromosome results were available within 24 hours of the chorionic villous sampling procedure, and were confirmed on amniotic fluid cell cultures after amniocentesis at 17 weeks' gestation and on cord blood at delivery.
The basic biochemical defect in most forms of severe combined immunodeficiency disease (SCID) is unknown, but a deficiency of the purine catabolic pathway enzyme adenosine deaminase (ADA, E.C.3.5.4.4.) is found in just over 20% of cases with the autosomally inherited form of the disorder. ' Treatment of patients with SCID by enzyme replacement has been attempted2 but a successful bone marrow transplant remains the only effective therapy, an option which is available to fewer-than 20% of patients who have an HLA compatible sib.3 Because of the generally poor prognosis, most at risk couples request prenatal diagnosis and selective termination of affected fetuses. Where the ADA deficient form of SCID is identified, prenatal diagnosis can be made by assay of the enzyme in cultured amniotic fluid cells after amniocentesis at 16 to 18 weeks' gestation,45 or by analysis of fetal blood samples by enzymology or fetal lymphocyte typing.6 7 We report here the early prenatal investigation of a pregnancy at risk for SCID and ADA deficiency using uncultured cells from chorionic villi obtained at eight weeks' gestation. Within 24 hours of the procedure, a deficiency of ADA in the fetus was excluded and the patient reassured.
Case report
The patient, a 25 year old P1+1, gave birth to her For the estimation of ADA activity, the villi were washed in 09% sodium chloride, resuspended in deionised water, and reduced to small fragments by chopping with scissors. The intracellular contents were released by sonication and the resulting suspension cleared by centrifugation at 10 000 g at 4°C for 10 minutes. The protein content of the supernatant was estimated by the Lowry method9 and adjusted to 0-3 to 0-5 mg/ml with deionised water.
Amniotic fluid cells were grown in Ham's F10 supplemented with 20% fetal calf serum and antibiotics. Cells were harvested by trypsinisation, washed in Hank's BSS and 0-9% sodium choride, and the cell pellet resuspended in deionised water and disrupted by sonication. Protein content of the centrifuged supernatant was adjusted to 0-2 to 0 3 mg/ml before assay.
Packed red cells from cord blood collected in heparin were lysed with deionised water and the haemolysate further diluted to a haemoglobin concentration of 0 5 to 1-0 g/dl.
Lysates of chorionic villi, amniotic fluid cells or red cells were assayed for ADA activity under identical conditions, using a modification of the radioassay method described previously."1 A total of 5 Rl of sample supernatant was mixed with 20 itl of 0-25 molIl Tris-HCl, pH 7-4, containing 0-35 mmol/l '4C-adenosine. The reaction solution was covered with two drops of oil (paraffin:hexadecane, 80:20) to prevent evaporation and the tubes incubated at 37°C for one hour. The reaction was stopped by adding 5 RI of cold 20% trichloroacetic acid and the precipitated proteins removed by high speed centrifugation. The labelled products and unused substrate in 2 1 l of the clear supernatant were separated by ascending thin layer chromatography on Polyethylimine cellulose-F (PEI-F, Merck) with 5% Na2HPO4 as solvent. Phytohaemagglutinin stimulated cultures of lymphocytes from cord blood showed the presence of a large number of mitotic cells indicating normal lymphocyte proliferation, thus supporting the prenatal diagnosis of a pregnancy unaffected by severe combined immunodeficiency and adenosine deaminase deficiency. As yet the risk to a continuing pregnancy after chorionic villi sampling cannot be accurately defined because of the limited experience obtained with a small number of diagnostic cases and the added complication of a high rate of spontaneous abortion in early pregnancy. However, provided the true risk is low and fetal tissue samples of adequate size uncontaminated with blood or maternal decidua can be obtained, then chorionic villi sampling is likely to become the method of choice for the prenatal diagnosis of a variety of metabolic diseases.
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